[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_12467 

# __Vulnerability of pharmaceutical supply chains__

## Articles mentionning the risk

* [Van_barneveld_covid-19_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_529.md)

## Mitigations of this risk

* [Diversifying sources of pharmaceutical ingredients, promoting local pharmaceutical production, and investing in stockpiling essential medicines](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_14384.md)

## Name of the risk

Shortages of essential medicines during pandemics or global crises

## People affected by this risk

* [Global population relying on essential medicines](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_10194.md)

## Stakeholders who can mitigate this risk

* [And healthcare organizations](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_47.md)
* [Governments](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_1389.md)
* [Pharmaceutical industry](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_3087.md)

## Technologies linked to the risk

* [And supply chain monitoring tools](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_4043.md)
* [Pharmaceutical manufacturing technologies](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_13564.md)
* [Quality control systems](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_14644.md)

## This Risk belongs to this RiskGroup

* [Infrastructure risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_2.md)

